Abstract
This Frost & Sullivan research service titled European Autoimmune Disease
Therapeutics Market provides an overview of current treatment options, drugs
in pipeline and technological advancements in the market. It also a complete
analysis of key market drivers, restraints and revenues involved in the
current rheumatoid arthritis and multiple sclerosis medications. In this
research, Frost & Sullivan' s expert analysts thoroughly examine the following
therapeutics markets for rheumatoid arthritis and multiple sclerosis.
This research service is available through our Pharmaceutical & Biotechnology
Growth Partnership Services program. With this program you receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
